ASCENTAGE-B(06855): The Chinese and English abbreviations will no longer include the "B" marker.
Ascent Medical-B (06855) announced that, due to the inapplicability of relevant rules, the company's Chinese and English abbreviations will no longer include the letter "B" starting from June 1, 2026. The company's shares will be traded on the Stock Exchange under the new English stock abbreviation "ASCENTAGE" and Chinese stock abbreviation "". The company's stock code will remain unchanged as "6855".
ASCENTAGE-B (06855) announces that, due to the inapplicability of relevant rules, the company's Chinese and English abbreviations will no longer be marked "B" starting from June 1, 2026. The company's shares will be traded on the Stock Exchange of Hong Kong under the new English abbreviation "ASCENTAGE" and Chinese abbreviation "". The company's stock code will remain unchanged as "6855".
Related Articles
On May 27, XIAO NOODLES (02408) spent 1.7808 million Hong Kong dollars to repurchase 443,000 shares.
Shanghai Universal Biotech (301166.SZ) plans to repurchase company shares ranging from 15 million to 30 million yuan.
AB&B BIO-TECH-B (02627) appoints Lei Meijia as an independent non-executive director.
On May 27, XIAO NOODLES (02408) spent 1.7808 million Hong Kong dollars to repurchase 443,000 shares.
Shanghai Universal Biotech (301166.SZ) plans to repurchase company shares ranging from 15 million to 30 million yuan.
AB&B BIO-TECH-B (02627) appoints Lei Meijia as an independent non-executive director.
